Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
Flunarizine is a calcium channel blocker traditionally used for the treatment of vertigo and
migraine. It also has the mechanism of action associated with antipsychotic activity (D2
receptor blockade), but has never been tested as such. The investigators hypothesis is that
flunarizine can be an atypical antipsychotic.